{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:13:54Z","timestamp":1761894834660},"reference-count":45,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2009,1,19]],"date-time":"2009-01-19T00:00:00Z","timestamp":1232323200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Endocrinology"],"published-print":{"date-parts":[[2009,11]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p><jats:bold>Background\u2002<\/jats:bold> Fat mass is increased in hypogonadal men and the changes are reversed by testosterone replacement. Testosterone administration enhances whole body fat oxidation (Fox). Fat is oxidized in the liver and in extra\u2010hepatic tissues.<\/jats:p><jats:p><jats:bold>Objective\u2002<\/jats:bold> To determine whether the stimulation of Fox by testosterone arises primarily from the liver or from extra\u2010hepatic tissues.<\/jats:p><jats:p><jats:bold>Design\/patients\u2002<\/jats:bold> This was an open\u2010label cross\u2010over study. Thirteen men with hypopituitarism (age 53\u00b71 \u00b1 4\u00b71\u00a0years) with both growth hormone (GH) and testosterone deficiency were studied sequentially after 2\u00a0weeks of treatment with transdermal testosterone (5\u00a0mg), no treatment, and stepwise incremental doses of oral crystalline testosterone (10, 20, 40 and 80\u00a0mg) in the absence of GH replacement.<\/jats:p><jats:p><jats:bold>Measurements\u2002<\/jats:bold> Serum testosterone, IGF\u2010I, metabolic effects [resting energy expenditure (REE) and Fox], SHBG, and thyroid binding globulin (TBG) as markers of excessive hepatic androgen exposure, were measured at the end of each treatment period.<\/jats:p><jats:p><jats:bold>Results\u2002<\/jats:bold> When compared to the no\u2010treatment phase, mean blood testosterone levels rose into the physiological range after transdermal testosterone delivery but did not significantly change after 10, 20, 40 or 80\u00a0mg oral testosterone treatment. Blood SHBG and TBG fell significantly with 80\u00a0mg oral testosterone dose but were unaffected by any other testosterone treatment. Fox increased significantly with transdermal but not with any dose of oral testosterone. Mean plasma IGF\u2010I and REE were unaffected by testosterone, regardless of the route or dose.<\/jats:p><jats:p><jats:bold>Conclusions\u2002<\/jats:bold> Short\u2010term testosterone administration does not stimulate hepatic fat oxidation but enhances whole body fat oxidation by acting on extra\u2010hepatic tissues.<\/jats:p>","DOI":"10.1111\/j.1365-2265.2009.03524.x","type":"journal-article","created":{"date-parts":[[2009,1,19]],"date-time":"2009-01-19T10:16:19Z","timestamp":1232360179000},"page":"715-721","source":"Crossref","is-referenced-by-count":23,"title":["Testosterone stimulates extra\u2010hepatic but not hepatic fat oxidation (Fox): comparison of oral and transdermal testosterone administration in hypopituitary men"],"prefix":"10.1111","volume":"71","author":[{"given":"Vita","family":"Birzniece","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Udo J.","family":"Meinhardt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David J.","family":"Handelsman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ken K. Y.","family":"Ho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2009,10,5]]},"reference":[{"key":"e_1_2_7_2_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF03345230"},{"key":"e_1_2_7_3_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.2005.02339.x"},{"key":"e_1_2_7_4_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajpendo.00483.2004"},{"key":"e_1_2_7_5_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.82.10.3213"},{"key":"e_1_2_7_6_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.83.6.1886"},{"key":"e_1_2_7_7_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI2773"},{"key":"e_1_2_7_8_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajpendo.2001.281.6.E1191"},{"key":"e_1_2_7_9_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2005-0173"},{"key":"e_1_2_7_10_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2004-1221"},{"key":"e_1_2_7_11_2","doi-asserted-by":"publisher","DOI":"10.2164\/jandrol.05058"},{"key":"e_1_2_7_12_2","doi-asserted-by":"publisher","DOI":"10.2164\/jandrol.107.002956"},{"key":"e_1_2_7_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(94)90181-3"},{"key":"e_1_2_7_14_2","doi-asserted-by":"publisher","DOI":"10.1159\/000178904"},{"key":"e_1_2_7_15_2","first-page":"366","article-title":"Plasma androgen levels in men after oral administration of testosterone or testosterone undecanoate","volume":"79","author":"Nieschlag E.","year":"1975","journal-title":"Acta Endocrinologica (Copenhagen)"},{"key":"e_1_2_7_16_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2605.1988.tb00999.x"},{"key":"e_1_2_7_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/0022-4731(87)91044-2"},{"key":"e_1_2_7_18_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0676.1988.tb00996.x"},{"key":"e_1_2_7_19_2","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-28-8-1105"},{"key":"e_1_2_7_20_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.83.6.2104"},{"key":"e_1_2_7_21_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2003-031802"},{"key":"e_1_2_7_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(78)90402-6"},{"key":"e_1_2_7_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(74)90216-5"},{"key":"e_1_2_7_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/0026-0495(88)90110-2"},{"key":"e_1_2_7_25_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.85.8.2670"},{"key":"e_1_2_7_26_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.81.12.4358"},{"key":"e_1_2_7_27_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.81.10.3469"},{"key":"e_1_2_7_28_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.82.2.407"},{"key":"e_1_2_7_29_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.85.8.2839"},{"key":"e_1_2_7_30_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2003-032006"},{"key":"e_1_2_7_31_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.84.8.2647"},{"key":"e_1_2_7_32_2","doi-asserted-by":"publisher","DOI":"10.1002\/j.1550-8528.1993.tb00618.x"},{"key":"e_1_2_7_33_2","first-page":"991","article-title":"The effects of testosterone treatment on body composition and metabolism in middle\u2010aged obese men","volume":"16","author":"Marin P.","year":"1992","journal-title":"International Journal of Obesity and Related Metabolic Disorders"},{"key":"e_1_2_7_34_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ijo.0801280"},{"key":"e_1_2_7_35_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0026-0495(97)90299-7"},{"key":"e_1_2_7_36_2","doi-asserted-by":"publisher","DOI":"10.1210\/endo-128-1-379"},{"key":"e_1_2_7_37_2","first-page":"791","article-title":"Effect of testosterone on abdominal adipose tissue in men","volume":"15","author":"Rebuffe\u2010Scrive M.","year":"1991","journal-title":"International Journal of Obesity"},{"key":"e_1_2_7_38_2","doi-asserted-by":"publisher","DOI":"10.1210\/endo.141.2.7293"},{"key":"e_1_2_7_39_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.81.3.1217"},{"key":"e_1_2_7_40_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1742-4658.2006.05503.x"},{"key":"e_1_2_7_41_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-2004-823023"},{"key":"e_1_2_7_42_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.83.5.1797"},{"key":"e_1_2_7_43_2","doi-asserted-by":"publisher","DOI":"10.1507\/endocrj1954.31.277"},{"key":"e_1_2_7_44_2","doi-asserted-by":"publisher","DOI":"10.1080\/tam.6.1.1.7"},{"key":"e_1_2_7_45_2","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1080\/tam.5.1.47.51","article-title":"Effects of androgen supplementation therapy on partial androgen deficiency in the aging male: a preliminary study","volume":"5","author":"Li J.Y.","year":"2002","journal-title":"The Aging Male"},{"key":"e_1_2_7_46_2","doi-asserted-by":"publisher","DOI":"10.1093\/gerona\/58.7.M618"}],"container-title":["Clinical Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2265.2009.03524.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2265.2009.03524.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,15]],"date-time":"2023-10-15T14:27:00Z","timestamp":1697380020000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2265.2009.03524.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,10,5]]},"references-count":45,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2009,11]]}},"alternative-id":["10.1111\/j.1365-2265.2009.03524.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2265.2009.03524.x","archive":["Portico"],"relation":{},"ISSN":["0300-0664","1365-2265"],"issn-type":[{"value":"0300-0664","type":"print"},{"value":"1365-2265","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,10,5]]}}}